1. Home
  2. ENOV vs IOSP Comparison

ENOV vs IOSP Comparison

Compare ENOV & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • IOSP
  • Stock Information
  • Founded
  • ENOV 1995
  • IOSP 1938
  • Country
  • ENOV United States
  • IOSP United States
  • Employees
  • ENOV N/A
  • IOSP N/A
  • Industry
  • ENOV Fluid Controls
  • IOSP Major Chemicals
  • Sector
  • ENOV Industrials
  • IOSP Industrials
  • Exchange
  • ENOV Nasdaq
  • IOSP Nasdaq
  • Market Cap
  • ENOV 1.8B
  • IOSP 2.1B
  • IPO Year
  • ENOV 2008
  • IOSP 1998
  • Fundamental
  • Price
  • ENOV $31.80
  • IOSP $78.29
  • Analyst Decision
  • ENOV Strong Buy
  • IOSP Strong Buy
  • Analyst Count
  • ENOV 6
  • IOSP 1
  • Target Price
  • ENOV $51.00
  • IOSP $155.00
  • AVG Volume (30 Days)
  • ENOV 809.0K
  • IOSP 244.3K
  • Earning Date
  • ENOV 11-05-2025
  • IOSP 11-04-2025
  • Dividend Yield
  • ENOV N/A
  • IOSP 2.15%
  • EPS Growth
  • ENOV N/A
  • IOSP N/A
  • EPS
  • ENOV N/A
  • IOSP 0.77
  • Revenue
  • ENOV $2,189,576,000.00
  • IOSP $1,790,700,000.00
  • Revenue This Year
  • ENOV $9.13
  • IOSP $0.25
  • Revenue Next Year
  • ENOV $6.39
  • IOSP $7.46
  • P/E Ratio
  • ENOV N/A
  • IOSP $101.39
  • Revenue Growth
  • ENOV 14.40
  • IOSP N/A
  • 52 Week Low
  • ENOV $25.47
  • IOSP $74.10
  • 52 Week High
  • ENOV $49.83
  • IOSP $128.35
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 47.12
  • IOSP 45.69
  • Support Level
  • ENOV $30.24
  • IOSP $77.95
  • Resistance Level
  • ENOV $32.43
  • IOSP $80.11
  • Average True Range (ATR)
  • ENOV 1.00
  • IOSP 1.62
  • MACD
  • ENOV -0.12
  • IOSP 0.17
  • Stochastic Oscillator
  • ENOV 26.45
  • IOSP 53.70

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

Share on Social Networks: